Immunome Inc. Purchase Agreements
4 Contracts & Agreements
- Asset Purchase Agreement dated October 25, 2024, by and among the Company, Zentalis Pharmaceuticals, Inc. and Zeno Management, Inc (Filed With SEC on October 29, 2024)
- Asset Purchase Agreement dated December 22, 2023, by and between the Registrant and Atreca, Inc (Filed With SEC on March 28, 2024)
- Asset Purchase Agreement dated February 5, 2024, by and between the Company and Ayala Pharmaceuticals, Inc (Filed With SEC on February 6, 2024)
- Securities Purchase Agreement, dated April 26, 2021, by and among Immunome, Inc. and the Purchasers signatory thereto (Filed With SEC on April 26, 2021)
